
    
      Study Design:

      Type of Study: Exploratory, translational, multicenter and multinational Phase II study.

      Patient Population:All patients from the intent-to-treat population with aCRC or mCRC,
      (incurable with any conventional multimodality approach) and who fulfil all inclusion and
      exclusion criteria.

      Number of Patients: 224

      Sample Type:

      Serial tissue and blood samples will be collected before (week 0), during (week 6, month 3
      and 6) and at the end of treatment (month 12).
    
  